Assistant or Associate Professor, Vaccine and Infectious Disease Division at the Fred Hutchinson Cancer Center and the Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, on the physician-scientist pathway.
The Fred Hutchinson Cancer Center (Fred Hutch) and the University of Washington (UW) are jointly recruiting a full-time faculty member at the Assistant or Associate Professor level without tenure due to funding (WOT), in the Vaccine and Infectious Disease Division (VIDD) of the Fred Hutch and the Division of Allergy and Infectious Diseases, Department of Medicine at the UW. The primary appointment will be in the VIDD of Fred Hutch. Academic appointment at the University of Washington will be commensurate with experience, qualifications, and academic rank. Assistant professors (WOT) are eligible for multi-year appointments and associate professors (WOT) hold indefinite appointments that both align with a 12-month service period (July 1-June 30). Faculty with 12-month service periods are paid for 11 months of service over a 12-month period (July-June), meaning the equivalent of one month is available for paid time off.
This position is paid directly by Fred Hutch and receives no UW compensation. Please refer to Fred Hutch for information about compensation for this position.
We are seeking a physician-scientist to develop an independent lab-based translational research program in the immunopathogenesis of respiratory viral diseases in humans. Ideally, the research will focus on those pathogens affecting immunocompromised hosts, as well as emerging viruses that cause substantial morbidity and mortality.
This new area of investigation broadens our existing research program, while building new capabilities (e.g., animal models) in this promising field. In addition to active laboratory research pursuits, the incumbent will be a member of the Infectious Disease Consult Team caring for patients in both the inpatient and outpatient departments. The successful candidate will demonstrate the capability of combining clinical infectious diseases care and research, particularly translational research and will be expected to obtain peer-reviewed extramural research funding once established at Fred Hutch.
Fred Hutch and UW faculty engage in teaching, research, and service. Teaching responsibilities will involve oversight of advanced practice providers and fellows during inpatient and outpatient rotations, and delivery of informal teaching sessions and formal lectures to providers and the general medical community.
We seek an individual with demonstrated passion for service, mentoring, patient care, and laboratory-based and clinical research that will contribute to the mission of Fred Hutch, known for its pioneering research and innovation in cancer and infectious diseases.
Fred Hutch is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington. With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.
At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an antiracist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, antiracism, and inclusion.
Anticipated Start Date: July 1, 2024